Xolair (omalizumab) - Roche, Novartis
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Nucala (mepolizumab) - GSK
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/42789457
 
Amandine Divaret Chauveau; Antoine Deschildre; Benoît Sterling; Dorothea Holter; Herman T den Dekker; Mariëlle W Pijnenburg; R Sharon Chinthrajah; Stéphanie Coopman; Stephanie Lejeune; Stéphanie Mallet; Thomas Eiwegger
 
Sep 26, 2026
 
Prev Next